Abstract:Factors associated with the atherosclerotic process, including inflammation, senescence-associated secretory phenotypes and telomere dysfunction are closely linked to senescence in VSMCs. However, whether senescent VSMCs are sufficient to cause atherosclerotic process and whether the phenotypes and risk factors of senescent VSMCs affect atherosclerotic pathogenesis are unclear. We investigated the mechanism of inhibition of atherosclerosis by the anti-aging agent metformin and whether attenuating risk factors senescent VSMCs affects atherogenesis. We performed in vitro studies including western blot, immunoprecipitation, RT-PCR, flow cytometry, immunofluorescence, FISH analysis, MMP zymography, and transfection of TERT siRNA. In vivo, to test the effect metformin on atherosclerotic lesion formation in ApoE-/- mice, male mice were divided into three groups (each, n = 5). After feeding the high-fat diet for 16 weeks, mice were sacrificed and the formation of atherosclerotic lesions in the aortas and the aortic sinuses were analyzed. Oleic acid (OA)-induced atherosclerotic pathogenesis in normal VSMCs showed marked senescence-associated features, manifested as increased b-gal positive cells and phenotypic switching of VSMCs in vitro; however, these phenomena were shown to be reversed by metformin. To determine what mechanism by metformin alleviates atherogenesis and senescent VSMC, we studied in the enhancement of telomere function by phosphorylating AMPK (Ser485) and PGC1 alpha. In our results, metformin showed increased the expression of p-AMPK (Ser485) as well as the phosphorylation of PGC1 alpha-dependent TERT expression and telomerase activity. Importantly, the depletion of TERT did not reduce risk factors for atherosclerosis and aged VSMCs despites metformin treatment in OA-induced atherosclerotic pathogenesis. We also found in the aortas of high-fat diet ApoE-/- mice, metformin treatment significantly attenuated atherosclerotic plaques and senescent VSMCs, and upregulated the expression of p-AMPK (Ser485)/p-PGC1 alpha and the enhancement of telomere function. The reduction of atherosclerotic pathogenesis in VSMCs and ApoE-/- mice is associated with significantly inhibited senescent phenotypes and risk factors. Increasing p-AMPK (Ser485)/p-PGC1 alpha by metformin the enhancement of telomere function mitigates senescent risk factors and may be a promising therapeutic strategy in atherosclerosis.

Metformin alleviates aging-associated cellular senescence of human adipose stem cells and derived adipocytes

Metformin Ameliorates D-Galactose-Induced Senescent Human Bone Marrow-Derived Mesenchymal Stem Cells by Enhancing Autophagy

In Vitro Treatment with Metformin Significantly Reduces Senescent B Cells Present in the Adipose Tissue of People with Obesity

RETRACTED: Metformin Ameliorates Senescence of Adipose-Derived Mesenchymal Stem Cells and Attenuates Osteoarthritis Progression via the AMPK-Dependent Autophagy Pathway (Retracted Article)

Metformin mitigates stress-induced premature senescence by upregulating AMPKα at Ser485 phosphorylation induced SIRT3 expression and inactivating mitochondrial oxidants

Metformin Enhances Autophagy and Normalizes Mitochondrial Function to Alleviate Aging-Associated Inflammation

STABILIZATION OF TELOMERE BY THE ANTI-AGING PROPERTY OF METFORMIN MITIGATES OLEIC ACID-INDUCED ATHEROSCLEROTIC PATHOGENESIS

Metformin alleviates human cellular aging by upregulating the endoplasmic reticulum glutathione peroxidase 7

228-LB: Metformin Alleviates Aging-Associated Metabolic Disorders through Intestinal AMPK-Mediated Gut Microbiome Alteration

Metformin promotes in vitro maturation of oocytes from aged mice by attenuating mitochondrial oxidative stress via SIRT3-dependent SOD2ac

Counteracting diabetes-induced adipose tissue derived-stromal cell senescence

Metformin-mediated effects on mesenchymal stem cells and mechanisms: proliferation, differentiation and aging

Metformin prevents murine ovarian aging

Telomere stabilization by metformin mitigates the progression of atherosclerosis via the AMPK-dependent p-PGC-1α pathway

Metformin Protects PC12 Cells and Hippocampal Neurons from H2O2‐induced Oxidative Damage Through Activation of AMPK Pathway

Metformin mitigates SASP secretion and LPS-triggered hyper-inflammation in Doxorubicin-induced senescent endothelial cells

Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults

Targeting senescent cells alleviates obesity-induced metabolic dysfunction

Anti-Aging Effect of Adipose-Derived Stem Cells in a Mouse Model of Skin Aging Induced by D-Galactose

Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms

Metformin Rescues the Impaired Osteogenesis Differentiation Ability of Rat Adipose-Derived Stem Cells in High Glucose by Activating Autophagy